RE:RE:RE:RE:RE:RE:RE:Last TimeBunge wrote: bencro wrote: Bunge ... I assume that if it doesn't work, you'll blame the CEO? The think is that all the science is ready. Just waiting after that first patient. So you still have time to sell. Otherwise, you'll have been warned that now, failure or success, you had plenty of time to take action.
Of course not. He's not a scientist and has no control over that at this point.
Only thing I'll blame him for is, if not for him, I think we'd be solidly in the $1-$2 range right now.
I would have recouped my initial investment under solid leadership.
So won't blame him for any failure in the science. Just for losing a substantial chunk of my $68,000.
Cheers
Quite true. $1-2 is the reasonable range we should sit, if not for those 2 stupid pp at huge discounts, we could have get more long-term shareholders to support over $1 for sure,the 2 stupid pp just scared away lots of potential investors, who would like to put their hard earned money into a company that doesn't care long-term shareholders ' value by doing stupid dilution again and again at lower and even lower price level with a lots of great scientific news all the way , this is called stupid management if not an idiots style, yes ,I got the chance to buy even lower and could average down ,but like shareholders of toade1313 and Ionde, we all would like to see the share price steady up . This is the right way to run the company and to make a great success.